TECHINSA Awards Early Stage Commercialisation Grant to GPN Vaccines

TECHINSA Awards Early Stage Commercialisation Grant to GPN Vaccines

The South Australian Early Commercialisation Fund administered by TechInSA has awarded GPN Vaccines $300,000.



Protecting children and adults from the world’s foremost bacterial pathogen